The dry eye medication market size has grown rapidly in recent years. It will grow from $11.01 billion in 2024 to $12.37 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to aging population, rising number of contact lens users, increase in disposable income, increase in number of treatment options, increase in number of allergies, rise in consumption of unhealthy or improper diets, and prevalence of diabetes mellitus.
The dry eye medication market size is expected to see rapid growth in the next few years. It will grow to $18.71 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to rising laser surgeries, rising screen time, busy lifestyles, the increasing burden of diabetes, increase in prevalence of dry eye disease, promising pipeline for dry eye disease, and side effects of other medications. Major trends in the forecast period include developing preservative-free eye drops, investing in research and development of new and advanced drugs, developing innovative drugs to survive in the market, developing non-steroidal anti-inflammatory ophthalmic drugs for the treatment of dry-eye syndrome, focusing on incorporating modern techniques, and developing combination therapies for the treatment of dry eye diseases.
Get Your Free Sample of The Global Dry Eye Medication Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3807&type=smp
How has the dry eye medication market evolved, and what factors have shaped its growth?
The increased number of cases of dry eye disease results in an increased demand for its treatment. Factors such as aging, lack of vitamin A, wearing lenses, eye surgeries, direct contact with dry wind or smoke, and exposing one’s eyes to screens for a long duration increase the occurrence of the dry eye more likely. For example, a survey conducted by the American Academy of Ophthalmology reported that in the USA, nearly 3.2 million women and 1.68 million men, over the age of 50 were affected by dry eye syndrome. Similarly, a study conducted by the Indian Journal of Ophthalmology indicated a 32% prevalence of dry eye disease in the Northern part of India. the rising prevalence of the disease would increase the demand for its treatment and ultimately facilitate the growth of the dry eye medication market.
What are the major segments of the dry eye medication market?
The dry eye medication market covered in this report is segmented –
1) By Type Of Product: Aqueous, Evaporative, Aqueous and Evaporative
2) By Delivery System: Liquid, Gel, Ointment, Other Delivery System
3) By Prescription Type: OTC Drugs, Prescription Drugs
4) By End-User: Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Aqueous: Artificial Tears (lubricating eye drops), Prescription Eye Drops, Ophthalmic Solutions
2) By Evaporative: Punctal Plugs (to reduce tear drainage), Lipid-Based Eye Drops, Eye Ointments (with lipid components)
3) By Aqueous and Evaporative: Combination Eye Drops (formulated to address both aqueous And evaporative dry eye), Multi-Action Eye Care Products
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/dry-eye-medication-global-market-report
Which companies dominate the dry eye medication market?
Major companies operating in the dry eye medication market include Allergan plc, Alcon Inc., Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., OASIS Medical, Inc., VISUfarma B.V., Sun Pharmaceutical Industries Limited, Bayer AG, Pfizer, Johnson & Johnson, Daiichi Sankyo, Zhaoke Ophthalmology Pharmaceutical, Vision gain, Implandata ophthalmic products GmbH, The Geuder Group, Novamedika, Aflofarm Farmacja Polska, VUAB Pharma Inc., Herzig Eye Institute, Thomas Eye Group, Alimera Sciences, Eyegate, Neurotech, Opthotech, Eyepoint pharmaceuticals, ReGenTree, LLC, Regenerx Biopharmaceuticals Inc, shire, Gama Vision, Biolab Pharma, Mitotech, Novaliq GmbH, Horus Pharma, Prestige Consumer Healthcare Inc., Azura Ophthamics Ltd, Similasan, Hoya Corporation, Adcock Ingram.
How will evolving trends contribute to the growth of the dry eye medication market?
Major companies operating in the dry eye medication market are developing innovative products, such as Cyclosporine ophthalmic solutions, to stimulate tear production, reduce ocular inflammation, and provide long-term relief. Cyclosporine ophthalmic solutions are prescription eye drops containing the immunosuppressant cyclosporine, used primarily to treat dry eye disease by increasing tear production and reducing inflammation in the eyes. For instance, in June 2023, Novaliq GmbH, a Germany-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval for VEVYE (cyclosporine ophthalmic solution) 0.1% for the treatment of the signs and symptoms of dry eye disease. VEVYE (development name CyclASol) is the first and only cyclosporine solution specifically approved for treating the signs and symptoms of dry eye disease, showing efficacy within just four weeks of treatment. Formulated with a novel, water-free excipient, VEVYE addresses unmet patient needs by offering a fast-acting and well-tolerated therapy for dry eyes. Unlike traditional solutions, it is free from water, anti-microbial preservatives, oils, and surfactants, which eliminates concerns related to pH and osmolarity.
What are the key regional dynamics of the dry eye medication market, and which region leads in market share?
The countries covered in the dry eye medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
What Does The Dry Eye Medication Market Report 2025 Offer?
The dry eye medication market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Dry eye medication refers to the drugs or medication that is used to treat dry eye by increasing your eye moisture. A multifactorial condition of the tears and ocular surface known as dry eye causes symptoms such as pain, blurred vision, and tear film instability, as well as the possibility of ocular surface injury.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3807
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
